Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · CHESTER, IL · NPI 1225471915
Verified facts
CMS Open Payments records show James Raymond Kirkpatrick, M.D., PH.D. received $22.07 in general payments during 2025 across 1 reported records.
Exact Sciences Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $22.07 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $22.07 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $22.07 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 487 | 121 |
| Omeprazole | Omeprazole | 460 | 103 |
| Levothyroxine Sodium | Levothyroxine Sodium | 369 | 80 |
| Lisinopril | Lisinopril | 361 | 95 |
| Furosemide | Furosemide | 337 | 79 |
| Sertraline Hcl | Sertraline Hcl | 312 | 63 |
| Losartan Potassium | Losartan Potassium | 309 | 81 |
| Amlodipine Besylate | Amlodipine Besylate | 286 | 77 |
| Pantoprazole Sodium | Pantoprazole Sodium | 269 | 75 |
| Duloxetine Hcl | Duloxetine Hcl | 247 | 53 |
| Metoprolol Succinate | Metoprolol Succinate | 235 | 65 |
| Famotidine | Famotidine | 234 | 57 |
| Potassium Chloride | Potassium Chloride | 234 | 51 |
| Eliquis | Apixaban | 231 | 39 |
| Metformin Hcl | Metformin Hcl | 220 | 56 |
| Hydrochlorothiazide | Hydrochlorothiazide | 215 | 71 |
| Metoprolol Tartrate | Metoprolol Tartrate | 208 | 52 |
| Tamsulosin Hcl | Tamsulosin Hcl | 203 | 44 |
| Trazodone Hcl | Trazodone Hcl | 196 | 43 |
| Allopurinol | Allopurinol | 181 | 40 |
| Gabapentin | Gabapentin | 181 | 39 |
| Simvastatin | Simvastatin | 144 | 41 |
| Warfarin Sodium | Warfarin Sodium | 132 | 14 |
| Prednisone | Prednisone | 131 | 89 |
| Carvedilol | Carvedilol | 126 | 32 |
| Finasteride | Finasteride | 123 | 26 |
| Doxycycline Hyclate | Doxycycline Hyclate | 118 | 100 |
| Lorazepam | Lorazepam | 111 | 28 |
| Farxiga | Dapagliflozin Propanediol | 105 | 24 |
| Metformin Hcl Er | Metformin Hcl | 101 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 98 | 17 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 96 | 28 |
| Spironolactone | Spironolactone | 92 | 19 |
| Jardiance | Empagliflozin | 89 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 87 | 21 |
| Mirtazapine | Mirtazapine | 86 | 18 |
| Montelukast Sodium | Montelukast Sodium | 86 | 19 |
| Tramadol Hcl | Tramadol Hcl | 85 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 84 | 19 |
| Meloxicam | Meloxicam | 80 | 30 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 79 | 21 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 76 | 17 |
| Ozempic | Semaglutide | 75 | 15 |
| Lovastatin | Lovastatin | 69 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 68 | 21 |
| Bupropion Xl | Bupropion Hcl | 68 | 14 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 64 | 57 |
| Ezetimibe | Ezetimibe | 63 | 14 |
| Synthroid | Levothyroxine Sodium | 62 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 57 | 21 |
| Nortriptyline Hcl | Nortriptyline Hcl | 55 | 15 |
| Trulicity | Dulaglutide | 51 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 49 | 16 |
| Alprazolam | Alprazolam | 48 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 48 | 17 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 48 | suppressed |
| Levetiracetam | Levetiracetam | 46 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 45 | suppressed |
| Xarelto | Rivaroxaban | 45 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 43 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 43 | 15 |
| Spiriva Handihaler | Tiotropium Bromide | 42 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 41 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 39 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 38 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 37 | suppressed |
| Cefdinir | Cefdinir | 37 | 31 |
| Sucralfate | Sucralfate | 37 | 13 |
| Ketoconazole | Ketoconazole | 36 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 36 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 35 | 13 |
| Cephalexin | Cephalexin | 34 | 27 |
| Buspirone Hcl | Buspirone Hcl | 33 | 11 |
| Memantine Hcl | Memantine Hcl | 33 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 32 | 30 |
| Pregabalin | Pregabalin | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | suppressed |
| Januvia | Sitagliptin Phosphate | 30 | suppressed |
| Risperidone | Risperidone | 30 | suppressed |
| Baclofen | Baclofen | 29 | suppressed |
| Bumetanide | Bumetanide | 29 | suppressed |
| Glipizide Er | Glipizide | 29 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 28 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 27 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 26 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 26 | 20 |
| Temazepam | Temazepam | 26 | suppressed |
| Torsemide | Torsemide | 26 | suppressed |
| Atenolol | Atenolol | 25 | suppressed |
| Azithromycin | Azithromycin | 25 | 25 |
| Clonazepam | Clonazepam | 24 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 23 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 22 | suppressed |
| Fluconazole | Fluconazole | 22 | 18 |
| Diclofenac Sodium | Diclofenac Sodium | 21 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 21 | suppressed |
| Calcitriol | Calcitriol | 20 | suppressed |
| Mupirocin | Mupirocin | 20 | 18 |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Celecoxib | Celecoxib | 18 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | 12 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 17 | suppressed |
| Glimepiride | Glimepiride | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 16 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 15 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 13 | suppressed |
| Humalog | Insulin Lispro | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 12 | 12 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Dutasteride | Dutasteride | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Pentoxifylline | Pentoxifylline | 12 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | suppressed |
| Dulera | Mometasone/Formoterol | 11 | suppressed |
| Gemtesa | Vibegron | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Modafinil | Modafinil | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Trueplus Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Ultra-Fine Original Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $22.07 · 1 records | Exact Sciences Corporation | The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error